INCY
Incyte CorporationNASDAQHealthcare$95.93+1.73%ClosedMarket Cap: $19.09B
As of 2026-04-06
Valuation
P/E (TTM)
14.84
PEG
0.00
P/B
3.67
P/S
3.71
EV/EBITDA
9.13
DCF Value
$120.00
FCF Yield
7.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.8%
Operating Margin
26.4%
Net Margin
25.0%
ROE
29.1%
ROA
19.2%
ROIC
20.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.51B | 90.9% | $383.9M | $299.3M | $1.46 | — |
| FY 2025 | $5.14B | 91.5% | $1.34B | $1.29B | $6.41 | — |
| Q3 2025 | $1.37B | 92.8% | $443.5M | $424.2M | $2.11 | — |
| Q2 2025 | $1.22B | 92.1% | $310.8M | $405.0M | $2.04 | — |
| Q1 2025 | $1.05B | 91.5% | $216.7M | $158.2M | $0.80 | — |
| Q4 2024 | $1.18B | 91.1% | $297.5M | $201.2M | $1.02 | — |
| FY 2024 | $4.24B | 91.1% | $80.1M | $32.6M | $0.15 | — |
| Q3 2024 | $1.14B | 91.0% | $169.5M | $106.5M | $0.54 | — |
| Q2 2024 | $1.04B | 91.1% | $-477.2M | $-444.6M | $-2.04 | — |
| Q1 2024 | $880.9M | 91.2% | $90.4M | $169.5M | $0.75 | — |
| Q4 2023 | $1.01B | 91.5% | $205.2M | $201.1M | $0.89 | — |
| FY 2023 | $3.70B | 91.5% | $651.8M | $597.6M | $2.65 | — |